Feb 27 (Reuters) - Brainchip Holdings Ltd BRN.AX:
BRAINCHIP EVALUATES REDOMICILING TO US
BRAINCHIP EVALUATES REDOMICILING TO US IN 2025
DECISION TO INVESTIGATE REDOMICILING WAS REACHED AFTER BOARD CONDUCTED AN EXTENSIVE STRATEGIC REVIEW OF COMPANY
BOARD DETERMINED THAT A SOLE US LISTING WAS IN BEST INTERESTS OF BRAINCHIP SHAREHOLDERS
WOULD SEEK TO SIMULTANEOUSLY DELIST SECURITIES FROM QUOTATION ON AUSTRALIAN SECURITIES EXCHANGE
Further company coverage: BRN.AX
((Reuters.Briefs@thomsonreuters.com;;))